Singh JA, Upshur R, Padayatchi N (2007) XDR-TB in South Africa: No time for denial or complacency. PLoS Med 4: e50. doi: 10.1371/journal.pmed.0040050.
[2]
Shah NS, Wright A, Drobniewski F, et al. (2005) Extreme drug resistance in tuberculosis (XDR-TB): Global survey of supranational reference laboratories for with resistance to second-line drugs. Int J Tuberc Lung Dis 9(Suppl 1): S77.
[3]
Holtz TH, Riektsina V, Zarovska E, Laserson KF, Wells CD, et al. (2005) XDR-TB: Extreme drug-resistance and treatment outcome under DOTS-Plus, Latvia, 2000–2002. Int J Tuberc Lung Dis 9(Suppl 1): S258.
[4]
Moll A, Gandhi NR, Pawinski R, Andrews J, Zeller K, et al. (2006) Identification of a multidrug-resistant tuberculosis cluster as a cause of death among HIV coinfected patients in rural South Africa. 13th Conference on Retroviruses and Opportunistic Infections; 7 February 2006; Denver, Colorado, United States of America. Poster O-115.
[5]
Centers for Disease Control and Prevention (CDC) (2006) Emergence of with extensive resistance to second-line drugs—Worldwide, 2000–2004. MMWR Morb Mortal Wkly Rep 55: 301–305.
[6]
Centers for Disease Control and Prevention (CDC) (2006) Notice to readers: Revised definition of extensively drug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 55: 1176.
